Daniel Wise
Cardiovascular Disease · Charlotte, NCNPI 1780625319
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,200 of the $24,205 with a category attached, or 83.5%. Amgen accounts for 73.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $19,257 and has fallen 99.9% since, to $23 in 2023.
Across 106 payments — averaging $228.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$18K
- Esperion Therapeutics, Inc.$5K
- Boehringer Ingelheim$210
- AstraZeneca$209
- Novartis$163
- Novo Nordisk$129
- plus $809 from 19 others
What the payments were for
- Speaking & faculty fees$20,20083%
- Travel & lodging$1,9208%
- Food & beverage$2,0428%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 24 | $17,760 |
| Esperion Therapeutics, Inc. | 3 | $4,925 |
| Boehringer Ingelheim | 7 | $210 |
| AstraZeneca | 8 | $209 |
| Novartis | 10 | $163 |
| Novo Nordisk | 8 | $129 |
| Johnson & Johnson | 8 | $128 |
| Boston Scientific | 4 | $102 |
| Sanofi-aventis U.S. LLC | 5 | $89 |
| Amarin Pharma, Inc. | 4 | $72 |
| Kowa Pharmaceuticals America, Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $43 |
| Lilly USA, LLC | 3 | $42 |
| Edwards Lifesciences | 2 | $42 |
| AbbVie | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $36 |
| Merck | 2 | $29 |
| W. L. Gore & Associates, Inc. | 1 | $23 |
| Pfizer | 1 | $22 |
| Aegerion Pharmaceuticals, Inc. | 1 | $17 |
| Gilead | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Vivus LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,205 in reported general payments places this provider in the 85th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Other cardiovascular disease in Charlotte
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
- Sanjeev GulatiCharlotte$406K
- Richard BrowneCharlotte$379K
- Rohit MehtaCharlotte$189K
- Brian PowellCharlotte$160K
- Nicole Cyrille-SupervilleCharlotte$115K
- Noreen KellyCharlotte$84K
- Dermot PhelanCharlotte$76K
- Charles SimontonCharlotte$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.